Companies: 10,795·Total market cap: $144.5T
Urologix, Inc.

Urologix, Inc.

ULGXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2182
P/E Ratio—
52W High$0.0126
52W Low$0.0001
SEC Filings

Urologix, Inc. (ULGX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000882873 · ULGX · OTC · as of Jun 9, 2026

Filing snapshot

554
Total Filings
SC 13D/A
Latest Form
2016-07-12
Most Recent
1996
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000882873 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2014-09-19
Fiscal Year End
Sep 19, 2014
Accession No.
0000897101-14-001320
Primary Document
urologix143355_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000882873 · Accession 0000897101-14-001320

Latest Key Filings

10-QQuarterly Report
FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2015
2015-05-14
View 10-Q on SEC
8-KCurrent Report
FORM 8-K DATED JULY 9, 2015
2015-07-10Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SC 13D/ASC 13D/A
UROLOGIX 13D/A
2016-07-12
View
SC 13D/ASC 13D/A
ULGX 13D/A
2016-05-17
View
SC 13D/ASC 13D/A
SC 13D/A
2016-03-25
View
SC 13D/ASC 13D/A
ULGX 13D/A
2016-02-23
View
SC 13DActivist Ownership Report
ULGX0205
2016-02-05
View
SC 13D/ASC 13D/A
ULGXYE15
2016-02-01
View
SC 13D/ASC 13D/A
SC 13D/A
2015-11-04
View
15-12G15-12G
FORM 15
2015-07-10
View
8-KCurrent Report
FORM 8-K DATED JULY 9, 2015
2015-07-10
View
SC 13D/ASC 13D/A
UROLOGIX INC 13D/A
2015-07-07
View
SDSD
FORM SD
2015-05-29
View
10-QQuarterly Report
FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2015
2015-05-14
View
8-KCurrent Report
FORM 8-K DATED MAY 12, 2015
2015-05-13
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2015-04-02
View
8-KCurrent Report
FORM 8-K DATED MARCH 17, 2015
2015-03-23
View
Showing 1–15 of 379 filingsForm 4 / 144 hidden· 554 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000882873  |  Exchange: OTC · Healthcare

Urologix, Inc. (OTC: ULGX) has submitted 554 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1996. As a Healthcare sector company with CIK 0000882873, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Urologix, Inc.'s most comprehensive regulatory disclosure. The most recent Urologix, Inc. 10-K was filed on 2014-09-19 for fiscal year ending 2014. Historical ULGX 10-K annual reports are available from 1996 through 2014.

Investors researching Urologix, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ANTH SEC Filings →SYUP SEC Filings →SVSO SEC Filings →LPTI SEC Filings →COTQF SEC Filings →CANQF SEC Filings →THMO SEC Filings →PZRXQ SEC Filings →
→ ULGX Financials→ ULGX Earnings→ ULGX Insider Trades

Frequently Asked Questions

ULGX SEC Filings · 8 questions

Urologix, Inc. (ULGX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 554 filings and access original documents at no cost. Urologix, Inc.'s CIK is 0000882873.

ULGX SEC filingsUrologix, Inc. SEC documentsfind ULGX 10-K